Education
About Us
Working with TipRanks
Follow Us
Tenax Therapeutics (TENX)
NASDAQ:TENX
| Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ -7.57K | $ -113.33K | $ -108.98K | $ -114.75K | $ -107.28K |
| Operating Income | - | $ -11.05M | $ -32.73M | $ -9.87M | $ -8.56M |
| EBITDA | - | $ -10.93M | $ -32.36M | $ -9.74M | $ -8.29M |
| Net Income | $ -7.71M | $ -11.04M | $ -32.73M | $ -9.87M | $ -8.39M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 9.79M | $ 2.12M | $ 5.58M | $ 6.71M | $ 5.40M |
| Total Assets | $ 11.68M | $ 3.40M | $ 5.99M | $ 6.87M | $ 6.37M |
| Total Debt | $ 500.90K | $ 807.89K | $ 290.78K | $ 305.04K | $ 171.73K |
| Net Debt | $ -9.29M | $ -1.32M | $ -5.29M | $ -5.95M | $ -4.73M |
| Total Liabilities | $ 3.59M | $ 1.91M | $ 1.75M | $ 2.24M | $ 2.59M |
| Stockholders' Equity | $ 8.10M | $ 1.49M | $ 4.24M | $ 4.63M | $ 3.77M |
| Cash Flow | |||||
| Free Cash Flow | $ -5.90M | $ -12.02M | $ -10.86M | $ -9.28M | $ -7.56M |
| Operating Cash Flow | $ -5.90M | $ -12.01M | $ -10.86M | $ -9.27M | $ -7.56M |
| Investing Cash Flow | $ 2.84K | $ -2.32K | $ 452.61K | $ 20.11K | $ -1.65K |
| Financing Cash Flow | $ 13.57M | $ 8.55M | - | $ 10.60M | $ 96.50K |